Therapy for severe community-acquired pneumonia.
Berk
S L
SL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002442:Ceftazidime / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D010406:Penicillins / Q000627:therapeutic use; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D004917:Erythromycin; D002442:Ceftazidime